Truly Labs

Truly Labs is a Swedish preclinical contract research and strategic consultancy firm that accelerates drug development for biotech and pharma clients. The company provides a full-service partnership model, combining strategic advice with access to modern, specialized laboratories for pharmacology, biomarker identification, and performance testing under IVDR. Led by CEO Karin von Wachenfeldt, Truly leverages a team with deep experience from both commercial drug development and academic research to bridge the gap between early-stage research and clinical trials.

Integrated preclinical service and consultancy model leveraging translational science, specialized in vitro/in vivo laboratories, and IVDR-ready diagnostic validation capabilities.

Truly Labs competes in the fragmented preclinical CRO and consultancy market, facing competition from large global players (e.g., Labcorp, Charles River), specialized niche CROs, and academic core facilities. Its differentiation lies in its strong translational consultancy layer combined with hands-on lab services, a model that competes with other boutique strategic advisory firms.